European Generic Markets: How Regulatory Approaches Across the EU Shape Drug Access and Pricing
The EU's generic drug approval system is complex, with four different pathways, inconsistent national rules, and major reforms in 2025 that will speed up access but also change how manufacturers compete. Learn how these changes affect drug availability and pricing across Europe.
Read More